Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 346, Issue 2, 2006, Pages 447-453

  Srivastava, Janmejai K ^a,b   Gupta, Sanjay ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cancer chemoprevention; Cell cycle arrest; Palm oil; Prostate cancer; Tocotrienol rich fraction

Indexed keywords

ALPHA TOCOTRIENOL; PALM OIL;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; PLANT OILS; PROSTATIC NEOPLASMS; TOCOTRIENOLS;

HUMAN PAPILLOMAVIRUS;

EID: 33745176559     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.147     Document Type: Article

References (41)

1. Sporn M.B., and Suh N. Chemoprevention: an essential approach to controlling cancer. Nat. Rev. Cancer 2 (2002) 537-543
2. Conney A.H. Tailoring cancer chemoprevention regimens to individual. J. Cell Biochem. 91 (2004) 277-286
3. Tsao A.S., Kim E.S., and Hong W.K. Chemoprevention of cancer. Cancer J. Clin. 54 (2004) 150-180
4. Shukla S., and Gupta S. Dietary agents in the chemoprevention of prostate cancer. Nutr. Cancer 53 (2005) 18-23
5. Helzlsouer K.J., Huang H.Y., Alberg A.J., Hoffman S., Burkr A., Norkus E.P., Morris J.S., and Comstock G.W. Association between alpha-tocopherol, gamma-tocopherol, selenium and subsequent prostate cancer. J. Natl. Cancer Inst. 92 (2000) 2018-2022
6. Greenwald P., McDonald S.S., and Anderson D.E. An evidence-based approach to cancer prevention clinical trials. Eur. J. Cancer Prev. 11 (2002) S43-S47
7. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., Schrag D., Jamison P.M., Jemal A., Wu C.X., Feiedman C., Harlan L., Anderson J.W.R.N., and Pickle L.W. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 97 (2005) 1407-1427
8. Mehta R.G., and Pezzuto J.M. Discovery of cancer preventive agent from natural products: from plants to prevention. Curr. Oncol. Rep. 4 (2002) 478-486
9. Denis L., Morton M.S., and Griffiths K. Diet and its preventive role in prostatic disease. Eur. Urol. 35 (1999) 377-387
10. Kelloff G.J., Lieberman R., Steel V.E., Boon C.W., Lubet R.A., Kopelovich L., Malone W.A., Crowell J.A., Higley H.R., and Sigman C.C. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer. Urology 57 (2001) 46-51
11. Packer L., and Landvik S. Vitamin E: introduction to biochemistry and health benefits. Ann. NY Acad. Sci. 570 (1989) 1-6
12. Burton G.W., and Ingold K.U. Vitamin E as an in vitro and in vivo antioxidant. Ann. NY Acad. Sci. 570 (1989) 7-22
13. Christine W., Maurizio P., Michalis R., Thiele J.J., Traber M.G., and Packer L. Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Free Radic. Biol. Med. 22 (1997) 761-767
14. Stone W.L., Krishnan K., Campbell S.E., Qui M., Whaley S.G., and Yang H. Tocopherols and the treatment of colon cancer. Ann. NY Acad. Sci. 1031 (2004) 223-233
15. Nesaretnam K., Dorasamy S., and Dabre D. Tocotrienol inhibit growth of ZR-75-1 breast cancer cells. Int. J. Food Sci. Nutr. 51 (2000) S95-S105
16. Packer L., Weber S.U., and Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signaling. J. Nutr. 131 (2001) 369S-373S
17. Mizushina Y., Nakagawa K., Shibata A., Awata Y., Kuriyama I., Shimazaki N., Koiwai O., Uchyama Y., Sakaguchi K., Miyazawa T., and Yoshida H. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase λ and angiogenesis. Biochem. Biophys. Res. Commun. 339 (2006) 949-955
18. Guthrie N., Gapor A., Chambers A.F., and Carroll K.K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and positive MCF-7 human breast cancer cells by palm oil tocotrienol and Tamoxifen, alone and in combination. J. Nutr. 127 (1997) 544S-548S
19. Nesaretnam K., Stephen R., Dils R., and Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33 (1998) 461-469
20. Agarwal M.K., Agarwal M.L., Athar M., and Gupta S. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3 (2004) 1-7
21. Shah S.J., and Sylvester P.W. Gamma tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kB activity. Exp. Biol. Med. 230 (2005) 235-241
22. Sylvester P.W., Russell M., Ip M.M., and Ip C. Comparative effect of different animal and vegetable fats before and during carcinogen administration on mammary tumorigenesis, sexual maturation and endocrine function in rats. Cancer Res. 46 (1986) 757-762
23. Sundram K., Khor H.T., Ong A.S.H., and Pathmanathan R. Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz[a]anthracene. Cancer Res. 49 (1989) 1447-1451
24. Gould M.N., Haag J.D., Kennan W.S., Tanner M.A., and Elson C.E. A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am. J. Clin. Nutr. 53 (1991) 1068S-1070S
25. Nesaretnam K., Khor H.T., Ganeson J., Chong Y.H., Sundram K., and Gapor A. The effect of vitamin E tocotrienols from palm oil on chemically induced mammary carcinogenesis in female rats. Nutr. Res. 12 (1992) 879-892
26. Nesaretnam K., Ambra R., Selvaduray K.R., Radhakrishnan K.E., Reimann K., and Virgili F. Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 39 (2004) 459-467
27. Sylyester P.W., Nachnanl A., Sahh S., and Brisky K.P. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac. J. Clin. Nutr. 11 (2002) S429-S452
28. Bortner C.D., Nicklas B.E.O., and Cidlowski J.A. the role of DNA fragmentation in apoptosis. Trend Cell Biol. 5 (1995) 21-26
29. Schneider C. Chemistry and biology of vitamin E. Mol. Nutr. Food Res. 49 (2005) 7-30
30. Sundram K., Sambanthamurthi R., and Tan Y.A. Palm fruit chemistry and nutrition. Asia Pac. J. Clin. Nutr. 12 (2003) 355-362
31. Sen C.K., Khanna S., and Sashwati R. Tocotrienols: vitamin E beyond tocopherols. Life Sci. 78 (2006) 2088-2098
32. McIntyre B.S., Briski K.P., Gapor A., and Sylvester P.W. Antiproliferative and apoptotic effect of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 224 (2000) 292-301
33. Nesaretnam K., Ambra R., Selvaduray K.R., Radhakrishnan A., Canali R., and Virgili F. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann. NY Acad. Sci. 1031 (2004) 143-157
34. Banerjee A., Xu H.J., Araujo D., Takahashi R., Stanbridge E.J., and Benedict W.R. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. Cancer Res. 52 (1992) 6297-6304
35. Sun S.Y., Hail Jr. N., and Lotan R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 96 (2004) 662-672
36. Jianhua Z., and Ming X. Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Boil. 12 (2002) 84-89
37. Ricci M.S., and Zong W.X. Chemotherapeutic approaches for targeting cell death pathway. Oncologist 11 (2006) 342-357
38. Tolomeo M., and Simoni D. Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies. Curr. Med. Chem. Anticancer Agents 3 (2002) 387-401
39. Schwartz G.K., and Shah M.A. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23 (2005) 9408-9421
40. Vermeulen K., Van Bockstaele D.R., and Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36 (2003) 131-149
41. McDonald III E.R., and El-Deiry W.S. Cell cycle control as a basis for cancer drug development (Review). Int. J. Oncol. 16 (2000) 871-886